NSEDCP
RXDX

NJ State Employees Deferred Compensation Plan’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,000
Closed -$1.61M 493
2023
Q1
$1.61M Buy
15,000
+11,000
+275% +$1.18M 0.25% 97
2022
Q4
$440K Buy
+4,000
New +$440K 0.07% 289